GB9107368D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9107368D0
GB9107368D0 GB919107368A GB9107368A GB9107368D0 GB 9107368 D0 GB9107368 D0 GB 9107368D0 GB 919107368 A GB919107368 A GB 919107368A GB 9107368 A GB9107368 A GB 9107368A GB 9107368 D0 GB9107368 D0 GB 9107368D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919107368A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB919107368A priority Critical patent/GB9107368D0/en
Publication of GB9107368D0 publication Critical patent/GB9107368D0/en
Priority to EP92907701A priority patent/EP0579650A1/en
Priority to PCT/GB1992/000611 priority patent/WO1992017460A1/en
Priority to JP4507178A priority patent/JPH06505989A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB919107368A 1991-04-08 1991-04-08 Novel compounds Pending GB9107368D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB919107368A GB9107368D0 (en) 1991-04-08 1991-04-08 Novel compounds
EP92907701A EP0579650A1 (en) 1991-04-08 1992-04-06 Novel compounds
PCT/GB1992/000611 WO1992017460A1 (en) 1991-04-08 1992-04-06 Novel compounds
JP4507178A JPH06505989A (en) 1991-04-08 1992-04-06 Azalactam hydroxamic acid derivatives as collagenase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919107368A GB9107368D0 (en) 1991-04-08 1991-04-08 Novel compounds

Publications (1)

Publication Number Publication Date
GB9107368D0 true GB9107368D0 (en) 1991-05-22

Family

ID=10692843

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919107368A Pending GB9107368D0 (en) 1991-04-08 1991-04-08 Novel compounds

Country Status (4)

Country Link
EP (1) EP0579650A1 (en)
JP (1) JPH06505989A (en)
GB (1) GB9107368D0 (en)
WO (1) WO1992017460A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594006A (en) * 1993-03-18 1997-01-14 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives as matrix metalloproteinases inhibitors
AU672888B2 (en) * 1993-03-18 1996-10-17 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives as matrix metalloproteinases inhibitors
ES2144819T3 (en) * 1994-01-20 2000-06-16 British Biotech Pharm L-TERC-LEUCINA-2-PIRIDILAMIDA.
GB9423914D0 (en) * 1994-11-26 1995-01-11 British Biotech Pharm Polyether derivatives as metalloproteinase inhibitors
US5639746A (en) * 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
US5919940A (en) * 1995-01-20 1999-07-06 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
US5672598A (en) * 1995-03-21 1997-09-30 The Procter & Gamble Company Lactam-containing hydroxamic acids
US5917090A (en) * 1995-06-30 1999-06-29 British Biotech Pharmaceuticals Ltd. Matrix metalloproteinase inhibitors
AU711804B2 (en) 1995-11-23 1999-10-21 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
PT927183E (en) * 1996-08-28 2004-12-31 Procter & Gamble SPIROCYLIC INHIBITORS OF METALOPROTEASES
JP3539736B2 (en) * 1996-08-28 2004-07-07 ザ プロクター アンド ギャンブル カンパニー Phosphinamides as substrate metalloprotease inhibitors
CA2263932A1 (en) * 1996-08-28 1998-03-05 Yetunde Olabisi Taiwo 1,4-heterocyclic metalloprotease inhibitors
CZ62899A3 (en) * 1996-08-28 1999-07-14 The Procter & Gamble Company 1,3-diheterocyclic metalloprotease inhibitors
AU734834B2 (en) * 1996-08-28 2001-06-21 Procter & Gamble Company, The Heterocyclic metalloprotease inhibitors
BR9712019A (en) 1996-09-10 1999-08-24 British Biotech Pharm Derivatives of cytostatic hyroxamic acids
US6462023B1 (en) 1996-09-10 2002-10-08 British Biotech Pharmaceuticals, Ltd. Cytostatic agents
NZ503945A (en) 1997-07-31 2002-11-26 Procter & Gamble Metalloprotease-inhibiting amide derivatives
US6329418B1 (en) 1998-04-14 2001-12-11 The Procter & Gamble Company Substituted pyrrolidine hydroxamate metalloprotease inhibitors
NZ525513A (en) 1998-08-07 2004-09-24 Pont Pharmaceuticals Du Succinoylamino lactams as inhibitors of Abeta protein production
HRP990246A2 (en) 1998-08-07 2000-06-30 Du Pont Pharm Co Succinoylamino benzodiazepines as inhibitors of a beta protein production
BR9917082A (en) 1998-12-24 2001-11-06 Du Pont Pharm Co Compounds that inhibit the production of "beta" proteins, a method of treating neurological disorders associated with the production of "beta" -amyloid, pharmaceutical composition and, method of inhibiting y-secretase activity
KR20010102485A (en) 1999-03-03 2001-11-15 데이비드 엠 모이어 Dihetero-substituted metalloprotease inhibitors
NZ513831A (en) 1999-03-03 2001-09-28 Procter & Gamble Alkenyl- and alkynyl-containing metalloprotease inhibitors
US6696456B1 (en) 1999-10-14 2004-02-24 The Procter & Gamble Company Beta disubstituted metalloprotease inhibitors
US6525044B2 (en) 2000-02-17 2003-02-25 Bristol-Myers Squibb Company Succinoylamino carbocycles and heterocycles as inhibitors of a-β protein production
IL151250A0 (en) 2000-03-21 2003-04-10 Procter & Gamble Difluorobutyric acid metalloprotease inhibitors
BR0109328A (en) 2000-03-21 2003-06-10 Procter & Gamble Unsubstituted metalloprotease inhibitors containing heterocyclic side chain
US6495540B2 (en) 2000-03-28 2002-12-17 Bristol - Myers Squibb Pharma Company Lactams as inhibitors of A-β protein production
IL151576A0 (en) 2000-04-03 2003-04-10 Bristol Myers Squibb Pharma Co Cyclic lactams as inhibitors of a-beta protein production
AU2001253108A1 (en) 2000-04-03 2001-10-15 Bristol-Myers Squibb Pharma Company Cyclic lactams as inhibitors of a-beta protein production
CA2379445C (en) 2000-06-01 2007-08-21 Bristol-Myers Squibb Pharma Company Lactams substituted by cyclic succinates as inhibitors of a.beta. protein production

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1406A (en) * 1980-12-18 1988-04-22 Schering Corp Substituted dipeptides, processes for their preparation and pharmaceutical compositions containing them and their use in the inhibition of enkephalinase
EP0401963A1 (en) * 1989-04-13 1990-12-12 Beecham Group p.l.c. Phosphonopeptides with collagenase inhibiting activity
GB9000846D0 (en) * 1990-01-15 1990-03-14 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
JPH06505989A (en) 1994-07-07
WO1992017460A1 (en) 1992-10-15
EP0579650A1 (en) 1994-01-26

Similar Documents

Publication Publication Date Title
GB9107368D0 (en) Novel compounds
GB9114949D0 (en) Novel compounds
GB9104839D0 (en) Novel compounds
GB9123857D0 (en) Novel compounds
GB9107504D0 (en) Novel compounds
GB9112240D0 (en) Novel compounds
GB9107501D0 (en) Novel compounds
GB9113803D0 (en) Novel compounds
AP9100267A0 (en) Novel compounds
GB9105583D0 (en) Novel compounds
GB9105584D0 (en) Novel compounds
GB9105585D0 (en) Novel compounds
GB9105606D0 (en) Novel compounds
GB9105683D0 (en) Novel compounds
GB9106079D0 (en) Novel compounds
GB9106080D0 (en) Novel compounds
GB9106092D0 (en) Novel compounds
GB9106093D0 (en) Novel compounds
GB9106094D0 (en) Novel compounds
GB9106490D0 (en) Novel compounds
GB9106491D0 (en) Novel compounds
GB9107367D0 (en) Novel compounds
GB9107369D0 (en) Novel compounds
GB9107500D0 (en) Novel compounds
GB9107389D0 (en) Novel compounds